Effects of SGLT2 inhibitors on cardiovascular outcomes and mortality in type 2 diabetes: A meta-analysis

BACKGROUND: Optimal glycemic control is required to restrain the increase of cardiovascular events in patients with type 2 diabetes. The effects of sodium-glucose cotransporter-2 (SGLT-2) inhibitors on cardiovascular events and mortality in those patients are not well established. This meta-analysis...

Descripción completa

Detalles Bibliográficos
Autores principales: Zou, Cai-Yan, Liu, Xue-Kui, Sang, Yi-Quan, Wang, Ben, Liang, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
3800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6919451/
https://www.ncbi.nlm.nih.gov/pubmed/31804352
http://dx.doi.org/10.1097/MD.0000000000018245

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6919451/
https://www.ncbi.nlm.nih.gov/pubmed/31804352
http://dx.doi.org/10.1097/MD.0000000000018245

Ejemplares similares